tiprankstipranks
Taysha Gene Therapies, Inc. (TSHA)
NASDAQ:TSHA
US Market
TSHA
Taysha Gene Therapies
RESEARCH TOOLSreports
Want to see TSHA full AI Analyst Report?

Taysha Gene Therapies (TSHA) Income Statement

1,258 Followers

Taysha Gene Therapies Income Statement

Last quarter (Q4 2025), Taysha Gene Therapies's total revenue was $5.49M, an increase of 171.27% from the same quarter last year. In Q4, Taysha Gene Therapies's net income was $-27.85M. See Taysha Gene Therapies’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Mar 22
Total Revenue
$ 9.77M$ 8.33M$ 15.45M$ 2.50M$ 0.00
Gross Profit
$ 8.63M$ 8.33M$ 15.45M$ 15.00K$ 0.00
Operating Expenses
$ 119.13M$ 99.79M$ 87.89M$ 126.04M$ 173.27M
Depreciation and Amortization
$ 1.15M$ 1.25M$ 1.37M$ 2.49M$ 492.00K
EBITDA
$ -109.35M$ -87.95M$ -105.20M$ -159.73M$ -172.60M
Operating Income
$ -110.50M$ -91.46M$ -72.44M$ -126.03M$ -173.27M
Other Income/Expenses
$ 1.50M$ 2.16M$ -39.13M$ -39.99M$ -1.26M
Pretax Income
$ -109.00M$ -89.30M$ -111.57M$ -166.01M$ -174.52M
Net Income
$ -109.00M$ -89.30M$ -111.57M$ -166.01M$ -174.52M
Per Share Metrics
Basic EPS
$ -0.34$ -0.36$ -0.96$ -3.78$ -4.64
Diluted EPS
$ -0.34$ -0.36$ -0.96$ -3.78$ -4.64
Weighted Average Shares Outstanding
 319.71M 250.13M 116.12M 43.95M 37.65M
Weighted Average Shares Outstanding (Diluted)
 319.71M 250.13M 116.12M 43.95M 37.65M
Currency in USD

Taysha Gene Therapies Earnings and Revenue History